Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Antitumor Activity of ARR-002 in Adults With Locally Advanced or Metastatic Ovarian or Endometrial Cancer.
This is a Phase 1 study to assess safety, tolerability, pharmacokinetics, immunogenicity, and antitumor activity of ARR-002 in advanced or metastatic ovarian o…
Ovarian CancerEndometrial CancerPlatinum-resistant Ovarian Cancer (PROC)+2 more
Estimated
~$10 – $8,750
ArriVent BioPharma, Inc.NCT07755436
Phase 1
A Phase 1, First-in-human, Open-label Study to Evaluate the Safety, Tolerability, PK, and Preliminary Anti-tumor Activity of the Novel Oral CDK2 Degrader NKT3964 in Adults With Advanced/Metastatic Solid Tumors
The goal of the Dose Escalation phase of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity to determ…
Solid TumorAdvanced Solid TumorSolid Tumor, Adult+25 more
Estimated
~$10 – $8,750